Benedict RHB, Amato MP, Deluca J et al (2020) Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues. Lancet Neurol 19:860–871

PubMed  PubMed Central  Google Scholar 

Meca-Lallana V, Gascon-Gimenez F, Ginestal-Lopez RC et al (2021) Cognitive impairment in multiple sclerosis: diagnosis and monitoring. Neurol Sci 42:5183–5193

PubMed  PubMed Central  Google Scholar 

Vaughn CB, Jakimovski D, Kavak KS et al (2019) Epidemiology and treatment of multiple sclerosis in elderly populations. Nat Rev Neurol 15:329–342

PubMed  Google Scholar 

Magliozzi R, Reynolds R, Calabrese M (2018) MRI of cortical lesions and its use in studying their role in MS pathogenesis and disease course. Brain Pathol 28:735–742

CAS  PubMed  PubMed Central  Google Scholar 

Nelson F, Datta S, Garcia N et al (2011) Intracortical lesions by 3T magnetic resonance imaging and correlation with cognitive impairment in multiple sclerosis. Mult Scler 17:1122–1129

PubMed  PubMed Central  Google Scholar 

Calabrese M, Agosta F, Rinaldi F et al (2009) Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 66:1144–1150

PubMed  Google Scholar 

Mike A, Glanz BI, Hildenbrand P et al (2011) Identification and clinical impact of multiple sclerosis cortical lesions as assessed by routine 3T MR imaging. AJNR Am J Neuroradiol 32:515–521

CAS  PubMed  PubMed Central  Google Scholar 

Papadopoulou A, Müller-Lenke N, Naegelin Y et al (2013) Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis. Mult Scler 19:1290–1296

PubMed  Google Scholar 

Roosendaal SD, Moraal B, Pouwels PJ et al (2009) Accumulation of cortical lesions in MS: relation with cognitive impairment. Mult Scler 15:708–714

CAS  PubMed  Google Scholar 

Kidd D, Barkhof F, Mcconnell R et al (1999) Cortical lesions in multiple sclerosis. Brain 122(Pt 1):17–26

PubMed  Google Scholar 

Calabrese M, Filippi M, Gallo P (2010) Cortical lesions in multiple sclerosis. Nat Rev Neurol 6:438–444

PubMed  Google Scholar 

Nociti V, Romozzi M, Mirabella M (2024) Challenges in Diagnosis and Therapeutic Strategies in Late-Onset Multiple Sclerosis. J Pers Med 14

Alroughani R, Akhtar S, Ahmed S et al. (2016) Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis? PLoS One 11:e0165846

Lorefice L, Ferraro OE, Fenu G et al (2024) Late-onset multiple sclerosis: disability trajectories in relapsing-remitting patients of the Italian MS Registry. J Neurol 271:1630–1637

CAS  PubMed  Google Scholar 

Lotti CBC, Oliveira ASB, Bichuetti DB et al (2017) Late onset multiple sclerosis: concerns in aging patients. Arq Neuropsiquiatr 75:451–456

PubMed  Google Scholar 

Oliveira AI, Monteiro IR, Alferes AR et al (2024) Cognitive outcomes in late-onset versus adult-onset Multiple Sclerosis. Mult Scler Relat Disord 90:105845

PubMed  Google Scholar 

Holtzer R, Choi J, Motl RW et al (2023) Individual reserve in aging and neurological disease. J Neurol 270:3179–3191

PubMed  PubMed Central  Google Scholar 

Thompson AJ, Banwell BL, Barkhof F et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162–173

PubMed  Google Scholar 

Geurts JJ, Roosendaal SD, Calabrese M et al (2011) Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology 76:418–424

CAS  PubMed  Google Scholar 

Schmidt P, Gaser C, Arsic M et al (2012) An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis. Neuroimage 59:3774–3783

PubMed  Google Scholar 

Deluca J, Schippling S, Montalban X et al (2021) Effect of Ozanimod on Symbol Digit Modalities Test Performance in Relapsing MS. Mult Scler Relat Disord 48:102673

CAS  PubMed  Google Scholar 

Roxburgh RH, Seaman SR, Masterman T et al (2005) Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 64:1144–1151

CAS  PubMed  Google Scholar 

Mouresan EF, Mentesidou E, Berglund A et al (2024) Clinical Characteristics and Long-Term Outcomes of Late-Onset Multiple Sclerosis: A Swedish Nationwide Study. Neurology 102:e208051

CAS  PubMed  PubMed Central  Google Scholar 

Dimauro KA, Swetlik C, Cohen JA (2024) Management of multiple sclerosis in older adults: review of current evidence and future perspectives. J Neurol 271:3794–3805

PubMed  PubMed Central  Google Scholar 

Holtzer R, Verghese J, Wang C et al (2008) Within-person across-neuropsychological test variability and incident dementia. JAMA 300:823–830

CAS  PubMed  PubMed Central  Google Scholar 

Torrence ND, John SE, Gavett BE et al (2016) An Empirical Comparison of Competing Factor Structures for the Repeatable Battery for the Assessment of Neuropsychological Status: A Project FRONTIER Study. Arch Clin Neuropsychol 31:88–96

PubMed  Google Scholar 

Learmonth YC, Motl RW, Sandroff BM et al (2013) Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis. BMC Neurol 13:37

PubMed  PubMed Central  Google Scholar 

Calabrese M, De Stefano N, Atzori M et al (2007) Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch Neurol 64:1416–1422

PubMed  Google Scholar 

Calabrese M, Rocca MA, Atzori M et al (2010) A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis. Ann Neurol 67:376–383

PubMed  Google Scholar 

Parra Corral MA, Govindarajan ST, Stefancin P et al (2019) Characterization of gray-matter multiple sclerosis lesions using double inversion recovery, diffusion, contrast-enhanced, and volumetric MRI. Mult Scler Relat Disord 31:74–81

PubMed  Google Scholar 

Faizy TD, Broocks G, Thaler C et al (2019) Development of Cortical Lesion Volumes on Double Inversion Recovery MRI in Patients With Relapse-Onset Multiple Sclerosis. Front Neurol 10:133

PubMed  PubMed Central  Google Scholar 

Damasceno A, Damasceno BP, Cendes F (2014) The clinical impact of cerebellar grey matter pathology in multiple sclerosis. PLoS ONE 9:e96193

PubMed  PubMed Central  Google Scholar 

Santangelo G, Altieri M, Gallo A et al (2019) Does cognitive reserve play any role in multiple sclerosis? A meta-analytic study. Mult Scler Relat Disord 30:265–276

PubMed  Google Scholar 

Sandry J, Simonet DV, Brandstadter R et al (2021) The Symbol Digit Modalities Test (SDMT) is sensitive but non-specific in MS: Lexical access speed, memory, and information processing speed independently contribute to SDMT performance. Mult Scler Relat Disord 51:102950

PubMed  Google Scholar